Daily Company Scan — 5 Companies
🇱🇹 AtrandiDEEP DIVE
Deeptech · Lithuania · $25M
Develops life sciences technology solutions.
Deal angle: Series A funding with Practica Capital; growth equity candidate
Thesis: Atrandi’s life-sciences platform stands out against Baltic peers trading at 5–15x EV/EBITDA, offering a rare deeptech growth asset in a region dominated by mature, low-margin operators. A strategic acquirer gains proprietary microfluidics IP and a €20–25M entry into scalable European biotech tools. Primary risk is early-stage cash burn with no EBITDA visibility, unlike the profitable comps.
🇱🇹 Bagfactory
Sustainability · Lithuania
Develops sustainable packaging innovations.
Deal angle: Investment by Livonia Partners; PE growth candidate
Thesis: Bagfactory gives Livonia Partners a platform in Lithuania’s sustainable packaging niche, driven by tightening EU plastic rules and limited local targets. An acquirer secures growth assets that could command 7-9x EV/EBITDA, in line with Grigeo and Apranga, plus cross-border rollout potential. Main risk: thin sector margins (4.9-14.8%) may compress multiples if revenue scale remains modest.
Tandfeen Aarhus ApS
· Denmark
Private Danish company (gross-profit basis)
Deal angle: Erhvervsstyrelsen annual reports (CVR)
Thesis: Tandfeen Aarhus ApS offers a rare, undisclosed Danish dental-services asset with gross-profit reporting that could be acquired below Baltic healthcare/retail multiples (median 8x EV/EBITDA). A strategic buyer gains immediate Scandinavian platform and cross-border patient flow without listed-market premiums paid for Apranga or Tallink. Key risk is opaque private financials and potential earn-out leakage on unverified margins.
BeloCare ApS
· Denmark
Private Danish company (gross-profit basis)
Deal angle: Erhvervsstyrelsen annual reports (CVR)
Thesis: BeloCare ApS provides Baltic groups a low-risk foothold in Denmark’s private care segment via a gross-profit model, where regional buyers could apply 6-9x EV/EBITDA multiples seen in Apranga or Grigeo rather than higher Danish valuations. An acquirer secures stable cash flows and cross-border operational leverage with minimal public disclosure. Key risk: absent sector data limits precise margin benchmarking against the 4.9-14.8% Baltic peer range.
CROZZ Company ApS
· Denmark
Private Danish company (gross-profit basis)
Deal angle: Erhvervsstyrelsen annual reports (CVR)
Thesis: CROZZ provides a private Danish acquisition vehicle with gross-profit reporting that could support 8-15% EBITDA margins in line with Baltic peers like Apranga (8.6x) or Ekspress (8.0x). A strategic buyer gains low-visibility entry to Denmark’s regulated market for tuck-in or platform building at potentially sub-8x EV/EBITDA given the undisclosed size. Key risk: opaque sector data and limited public financials from CVR filings increase execution uncertainty.
Deep Dive
🇱🇹 Atrandi
Deeptech · Lithuania · Series A funding with Practica Capital; growth equity candidate
Company Overview
Atrandi develops proprietary microfluidics platforms for life-sciences applications, including single-cell analysis and droplet-based screening tools. Headquartered in Lithuania, the company operates at early-commercial scale with revenue below €10M and is pre-profit. Its technology targets academic and industrial biotech customers seeking higher-throughput, lower-cost alternatives to legacy systems.
Deal Context
The €23M Series A led by Practica Capital positions Atrandi as a growth-equity candidate rather than a near-term M&A target. Practica’s involvement signals credible local sponsorship and provides runway to expand sales teams and file additional IP. Strategic buyers—global life-science tool groups such as Danaher, Sartorius or Merck KGaA—would view the platform as a bolt-on for European microfluidics exposure, while regional PE funds may co-invest to build a Baltic deeptech cluster.
Valuation Context
Listed Baltic peers trade at 5.4–15.1x EV/EBITDA with EBITDA margins of 5–43%, reflecting mature, low-growth businesses. Atrandi’s lack of EBITDA precludes direct application of these multiples. A realistic private-company valuation for a revenue-sub-€10M deeptech asset is 8–12x forward revenue, implying a €20–30M post-money range after a 30–40% liquidity and scale discount to listed growth comparables. This ceiling is further compressed by the absence of recurring-revenue visibility typical in the sector.
Triage Verdict
REVIEW
- Fit: Strong sector and geography alignment with deeptech scarcity value, though size and pre-profit status limit immediate institutional mandates.
- Red flags: Minimal commercial traction, concentrated founder IP risk and no disclosed customer diversification data.
- Next step if GO: Request Practica data room and customer pipeline summary before committing to co-lead or anchor participation.
Key Risk
Sustained cash burn without clear ARR inflection could force a down-round or strategic sale at depressed terms before the platform reaches commercial scale.
Bottom line: Atrandi offers differentiated deeptech exposure but requires tighter commercial diligence before crossing from review to commitment.
Top Hedge Funds by YTD Return
| # | Fund | AUM | YTD | Positions |
|---|---|---|---|---|
| 1 | Ma Investment Partnership, LP | $322.6B | +167.4% | 18 |
| 2 | Shengqi Capital (Hong Kong) Ltd | $95.6B | +148.9% | 10 |
| 3 | Anther Capital Ltd | $3.8T | +143.5% | 31 |
| 4 | Central Asset Investments & Manag… | $261.4B | +133.7% | 63 |
| 5 | Oxbow Capital Management (HK) Ltd | $731.4B | +126.8% | 14 |
| 6 | AIHC Capital Management Ltd | $226.4B | +118.4% | 11 |
| 7 | Merck & Co., Inc. | $625.7B | +111.7% | 26 |
| 8 | Step Capital Management Pte. Ltd. | $467.4B | +104.8% | 53 |
| 9 | Amanah Holdings Trust | $1.6T | +102.9% | 40 |
| 10 | Grand Alliance Asset Management Ltd | $302.6B | +102.6% | 24 |
Hedge Fund Spotlight
Oxbow Capital Management (HK) Ltd
AUM $731.4B · 14 positions ·
+126.8% YTD
Top 5 Holdings
| Security | Value | Weight |
|---|---|---|
| SANDISK CORP | $110.5B | 24.3% |
| COHERENT CORP | $96.5B | 21.2% |
| SEAGATE TECHNOLOGY HLDNGS PL | $86.6B | 19.1% |
| BROADCOM INC | $86.1B | 19.0% |
| SEAGATE TECHNOLOGY HLDNGS PL | $74.5B | 16.4% |
IPO Pipeline Snapshot
Upcoming IPOs
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Research Alliance Corp IV | RACD | UNKNOWN | TBD | $75.0M |
| Luminous Acquisition | LUMIU | UNKNOWN | TBD | $120.8M |
| Gores Holdings XI, Inc. | GHXIU | UNKNOWN | TBD | $358.8M |
| Cartesian Growth Corp IV | CGCFU | UNKNOWN | TBD | $287.5M |
Pre-IPO Watchlist
| Company | Sector | Valuation |
|---|---|---|
| Anthropic | Artificial Intelligence | $965.0B |
| OpenAI | Artificial Intelligence | $894.3B |
| Databricks | Data and Analytics | $191.9B |
Deal Radar — Buyer ↔ Target Synergy Pairs
🇳🇴 Norway · 3 pairs
BUYER · PUBLIC
EQUINOR
EQNR.OL · $916.2B
→
3.90
TARGET · PRIVATE
A/S Norske Shell
Utvinning av naturgass · ~€2171.4M rev
Solid — pursue with focused integration plan.
Equinor gains the largest synergy lever from operational consolidation of overlapping Norwegian gas production assets; the main risk is execution friction from integrating a former Shell subsidiary with different systems and culture.
BUYER · PUBLIC
Skanska AB ser. B
SKA-B.ST · $110.4B
→
3.65
TARGET · PRIVATE
AF GRUPPEN NORGE AS
Bygging av broer og tunneler · ~€869.7M rev
Solid — pursue with focused integration plan.
Skanska gains immediate scale and local execution depth in Norwegian infrastructure where cost synergies from procurement and equipment sharing are credible. Revenue synergies remain modest due to client overlap, while organizational fit benefits from cultural proximity; the largest risk is execution distraction on large ongoing projects during integration.
BUYER · PUBLIC
Vår Energi ASA
VAR.OL · $121.2B
→
3.55
TARGET · PRIVATE
A/S Norske Shell
Utvinning av naturgass · ~€2171.4M rev
Solid — pursue with focused integration plan.
Largest lever is cost_operational consolidation of overlapping Norwegian E&P assets; biggest risk is regulatory scrutiny in a concentrated domestic upstream market plus execution on a large subsidiary integration.
🇪🇪 Estonia · 3 pairs
BUYER · PUBLIC
INCHCAPE PLC ORD 10P
INCH.L · $2.9B
→
3.75
TARGET · PRIVATE
TOYOTA BALTIC AS
Wholesale And Retail Trade; Repair Of Motor Vehicles And Motorcycles · ~€1008.6M rev
Solid — pursue with focused integration plan.
Inchcape's distribution platform creates strong cost and strategic synergies with Toyota Baltic's scale, primarily via procurement and Baltic market access. Realisation risk is moderate due to cross-border integration and typical revenue-synergy haircuts; cost synergies remain the clearest lever.
BUYER · PUBLIC
Fortum Corporation
FORTUM.HE · $17.9B
→
3.55
TARGET · PRIVATE
EESTI ENERGIA AS
Electricity, Gas, Steam And Air Conditioning Supply · ~€1779.3M rev
Solid — pursue with focused integration plan.
Fortum gains the clearest value from cost and strategic regional consolidation in the Nordic-Baltic energy corridor, with procurement and market-position synergies as the primary lever. Revenue and organizational realization will be tempered by regulated markets and state ownership, capping overall upside and requiring careful regulatory navigation.
BUYER · PUBLIC
E.ON SE N
EOAN.DE · $49.7B
→
3.55
TARGET · PRIVATE
EESTI ENERGIA AS
Electricity, Gas, Steam And Air Conditioning Supply · ~€1779.3M rev
Solid — pursue with focused integration plan.
Primary lever is cost/operational scale in energy procurement and trading; largest risk is organisational distance and slower realisation of Baltic synergies. Horizontal utilities fit supports a 3.55 composite after standard haircuts.
🇩🇰 Denmark · 3 pairs
BUYER · PUBLIC
DSV A/S
DSV.CO · $322.2B
→
3.65
TARGET · PRIVATE
Antoax Holding A/S
· ~€512.8M rev
Solid — pursue with focused integration plan.
DSV's scale delivers reliable cost synergies through operational consolidation of the Danish target, the largest lever. Main risk is limited visibility into Antoax's exact operations and modest revenue synergy probability, warranting conservative valuation.
BUYER · PUBLIC
INCHCAPE PLC ORD 10P
INCH.L · $2.9B
→
3.55
TARGET · PRIVATE
Toyota Danmark A/S
· ~€420.5M rev
Solid — pursue with focused integration plan.
Inchcape's core competency in automotive distribution yields strong cost and strategic fit with Toyota Danmark, primarily via operational consolidation and Nordic expansion. Revenue and organisational synergies are more modest due to limited cross-sell potential and integration complexity. Largest lever is cost take-out; largest risk is slower realisation from regulatory and brand-franchise constraints.
BUYER · PUBLIC
ATEA
ATEA.OL · $19.2B
→
3.55
TARGET · PRIVATE
Dell A/S
· ~€276.6M rev
Solid — pursue with focused integration plan.
Featured Agent
Legal & Regulatory Reviewer
diligence · Litigation, regulatory, and change-of-control consents — flagged.
Parses corporate minute books, litigation searches, and regulatory filings. Flags material breaches, open litigation, licensure gaps, and change-of-control consents required at close.
Its editable system prompt:
# Legal & Regulatory Reviewer You review legal and regulatory DD: corporate records, litigation, licensing, change-of-control. ## Output **Corporate & structure:** share register, board composition, material amendments, related-party transactions. **Open litigation:** table with: | Case | Jurisdiction | Status | Claim amount | Exposure | **Regulatory:** required licenses, active investigations, sanctions / GDPR / AML flags. **Change-of-control consents:** required at close — table with consent, counterparty, lead time. **Material contracts breach / amendment triggers on CoC.** **Bottom…